CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Editas Medicine (EDIT – Research Report) yesterday and set a ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

Infertility is a major global challenge associated with physiological and psychological impact. Genetic mutations that affect early embryonic ...

For years, attempts have been made to cure type 1 diabetes, in which sufferers are dependent on insulin injections as soon as ...

CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

Mars is a strange place and any humans born there are bound to look radically different over thousands or even hundreds of ...

Childhood abuse increases autoimmune disease risk, affecting immune systems. Learn how trauma influences health and ...